1. Home
  2. FSLR vs NTRA Comparison

FSLR vs NTRA Comparison

Compare FSLR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Solar Inc.

FSLR

First Solar Inc.

HOLD

Current Price

$225.01

Market Cap

29.2B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$208.72

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLR
NTRA
Founded
1999
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
32.9B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
FSLR
NTRA
Price
$225.01
$208.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
25
14
Target Price
$252.35
$253.79
AVG Volume (30 Days)
2.4M
1.1M
Earning Date
02-24-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
12.25
N/A
EPS
13.03
N/A
Revenue
$5,050,625,000.00
$2,116,676,000.00
Revenue This Year
$23.74
$33.95
Revenue Next Year
$20.13
$16.72
P/E Ratio
$17.32
N/A
Revenue Growth
31.16
38.17
52 Week Low
$116.56
$125.38
52 Week High
$285.99
$256.36

Technical Indicators

Market Signals
Indicator
FSLR
NTRA
Relative Strength Index (RSI) 43.27 37.99
Support Level $216.73 $204.04
Resistance Level $231.17 $213.96
Average True Range (ATR) 12.22 8.97
MACD -0.05 -1.65
Stochastic Oscillator 30.07 28.91

Price Performance

Historical Comparison
FSLR
NTRA

About FSLR First Solar Inc.

First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: